Merit Medical Systems Inc (MMSI)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	120,357	120,039	117,429	101,948	94,411	100,183	89,621	84,674	74,516	61,728	58,423	48,041	48,454	43,219	28,243	4,269	-9,843	-29,426	-29,815	-3,898
Revenue (ttm)	US$ in thousands	1,346,822	1,311,388	1,282,089	1,260,472	1,241,203	1,213,421	1,188,414	1,165,681	1,144,662	1,131,114	1,111,439	1,096,568	1,069,451	1,049,645	1,025,702	962,507	955,554	955,472	953,411	990,405
Net profit margin		8.94%	9.15%	9.16%	8.09%	7.61%	8.26%	7.54%	7.26%	6.51%	5.46%	5.26%	4.38%	4.53%	4.12%	2.75%	0.44%	-1.03%	-3.08%	-3.13%	-0.39%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $120,357K ÷ $1,346,822K
= 8.94%

Net profit margin is a key financial ratio that indicates the percentage of revenue that translates into net income after all expenses have been deducted. Reviewing the net profit margin data for Merit Medical Systems Inc from March 2020 to December 2024 reveals a fluctuating trend.

The net profit margin was negative in the first three quarters of 2020, indicating that the company was incurring losses during that period. However, there was a significant improvement by March 2021 when the net profit margin turned positive at 0.44%. This positive trend continued throughout 2021 and into 2022 with a steady increase in the net profit margin.

By the end of December 2023, the net profit margin reached a peak of 8.26%. This demonstrated the company's ability to generate more profit from its revenue during that period. Although there was a slight dip in the net profit margin by the end of December 2024 to 8.94%, it still remained at a healthy level.

Overall, the increasing trend in the net profit margin indicates that Merit Medical Systems Inc improved its profitability and operational efficiency over the analyzed period. It is essential for investors and stakeholders to monitor this ratio to assess the company's financial performance and sustainability.